Showing results (191-200 of 202) with videos related to
Sort By:
Pageof 21
Blood Advances|April 25, 2020
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopeniasXing Fan, Ronan Desmond, Thomas Winkler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemiaFrancis Giles, David Rizzieri, Judith Karp, et al.Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.Blood|March 22, 2003
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromesFrancis J Giles, Alison T Stopeck, Lewis R Silverman, et al.Blood Advances|April 24, 2020
Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemiaNicholas J Short, Keyur P Patel, Maher Albitar, et al.Haematologica|December 1, 2020
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndromeAlana Vicente, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignanciesKaren W L Yee, Anne Hagey, Srdan Verstovsek, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up resultsHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.Blood Cancer Journal|February 2, 2022
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithmsMaher Albitar, Hong Zhang, Andre Goy, et al.Blood Advances|July 30, 2020
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCLZijun Y Xu-Monette, Hongwei Zhang, Feng Zhu, et al.Pageof 21